Skip to content
10-K

Annual Report

CNBX PHARMACEUTICALS INC. CNBX

0001683168-23-008557

← back to feed
Filed
Nov 30, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Nov 29, 2023 28.31M sh
Shares Diluted FY 2023 · Aug 31, 2022 1.22M sh
Operating Cash Flow FY 2023 · Aug 31, 2022 −$1.68M
Cash And Equivalents FY 2023 · Aug 31, 2022 $117.52K
Current Liabilities FY 2023 · Aug 31, 2022 $2.44M
Current Assets FY 2023 · Aug 31, 2022 $198.29K
Total Assets FY 2023 · Aug 31, 2022 $811.17K
Eps Diluted FY 2023 · Aug 31, 2022 −$3.59
Eps Basic FY 2023 · Aug 31, 2022 −$3.59
Sga Expense restated FY 2023 · Aug 31, 2022 $1.8M
Rd Expense FY 2023 · Aug 31, 2022 $1.18M
Net Income FY 2023 · Aug 31, 2022 −$3.72M
Operating Income FY 2023 · Aug 31, 2022 −$2.95M
Revenue FY 2023 · Aug 31, 2022 $29.96K
Stockholders Equity FY 2023 · Aug 31, 2021 $1.81M